Cargando…

Impairment of T cell development and acute inflammatory response in HIV-1 Tat transgenic mice

Immune activation and chronic inflammation are hallmark features of HIV infection causing T-cell depletion and cellular immune dysfunction in AIDS. Here, we addressed the issue whether HIV-1 Tat could affect T cell development and acute inflammatory response by generating a transgenic mouse expressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fiume, Giuseppe, Scialdone, Annarita, Albano, Francesco, Rossi, Annalisa, Maria Tuccillo, Franca, Rea, Domenica, Palmieri, Camillo, Caiazzo, Elisabetta, Cicala, Carla, Bellevicine, Claudio, Falcone, Cristina, Vecchio, Eleonora, Pisano, Antonio, Ceglia, Simona, Mimmi, Selena, Iaccino, Enrico, Laurentiis, Annamaria de, Pontoriero, Marilena, Agosti, Valter, Troncone, Giancarlo, Mignogna, Chiara, Palma, Giuseppe, Arra, Claudio, Mallardo, Massimo, Maria Buonaguro, Franco, Scala, Giuseppe, Quinto, Ileana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561375/
https://www.ncbi.nlm.nih.gov/pubmed/26343909
http://dx.doi.org/10.1038/srep13864
Descripción
Sumario:Immune activation and chronic inflammation are hallmark features of HIV infection causing T-cell depletion and cellular immune dysfunction in AIDS. Here, we addressed the issue whether HIV-1 Tat could affect T cell development and acute inflammatory response by generating a transgenic mouse expressing Tat in lymphoid tissue. Tat-Tg mice showed thymus atrophy and the maturation block from DN4 to DP thymic subpopulations, resulting in CD4(+) and CD8(+) T cells depletion in peripheral blood. In Tat-positive thymus, we observed the increased p65/NF-κB activity and deregulated expression of cytokines/chemokines and microRNA-181a-1, which are involved in T-lymphopoiesis. Upon LPS intraperitoneal injection, Tat-Tg mice developed an abnormal acute inflammatory response, which was characterized by enhanced lethality and production of inflammatory cytokines. Based on these findings, Tat-Tg mouse could represent an animal model for testing adjunctive therapies of HIV-1-associated inflammation and immune deregulation.